EP3520788
EDARAVONE FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS OR PREVENTING PROGRESSION OF PHASE OF AMYOTROPHIC LATERAL SCLEROSIS
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
5.9.2012EP published:
11.2.2026EP application number:
19165074.6
EPO information:
European Patent Register
Max expiry date:
4.9.2032Expiry date:
4.9.2026
Title in English:
EDARAVONE FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS OR PREVENTING PROGRESSION OF PHASE OF AMYOTROPHIC LATERAL SCLEROSISLanguage of the patent:
English
Timeline
Today
5.9.2012EP application
11.2.2026EP Publication
4.9.2026Expires
Owner
Name:
Mitsubishi Tanabe Pharma CorporationAddress:
2-10, Dosho-machi 3-chome Chuo-ku, Osaka-shi Osaka 541-8505, JP
Inventor
Name:
YONEOKA, TakatomoAddress:
Osaka 541-8505, JP
Priority
Number:
2011192288Date:
5.9.2011Country:
JP
Classification
Categories:
A61K 31/4152, A61P 11/16, A61P 21/02, A61P 21/00, A61P 21/04, A61P 25/00, A61P 25/28, C07D 231/26